Report ID :10151903 |
Published Date : 21 Oct 2022 |
Report Format : |
Delivery Timeline :48-72 Business Hours
"By 2022, the global IVD quality control product market is expected to reach USD ~1.5 billion, with a compound annual growth rate of 4% during the period 2022-2030. IVD quality control is a sample/material testing system used to verify the reliability of IVD to ensure the accuracy of test results and to evaluate the impact of environmental conditions and operator performance on the test results. This is due to the increase in the demand for third-party quality control, the increase in the number of accredited clinical laboratories, and the strict requirements for the use of control by certification bodies and regulatory agencies. During the review period, poor refund policies and strict regulatory standards are expected to hinder market growth.
MARKET SEGMENT REVIEW :
The global in vitro diagnostic quality control market is segmented by product type, application, manufacturer type, end user, and region. According to product types, the market is divided into QA, IVD QA data management software and QA services. The QA department dominated the global market by product type in 2020 and is expected to maintain its dominant position by 2022, achieving the fastest compound annual growth rate of 5% during the forecast period.
This is attributed to the increased demand for quality control to verify the accuracy, precision and reliability of IVD test results. Market end users include hospitals, clinical laboratories, academic and research institutions, etc. The hospital sector dominated the IVD QA market in 2020 and is expected to maintain its dominant position during the forecast period. According to the manufacturer, the market is divided into instrument manufacturer control and independent manufacturer control, including third-party control and instrument-specific control.
The independent manufacturer control department occupied most of the market in 2020, and due to the increased demand for multi-analyte and third-party control, it is expected to grow at the fastest compound annual growth rate during the forecast period. The quality control market includes immunochemistry, clinical chemistry, hematology, molecular diagnostics, coagulation, microbiology, etc.
The immunochemistry application sector dominated the global per-applied IVD quality control market in 2020, and it is expected to maintain this dominance during the analysis period due to the increased demand for high-sensitivity immunochemical tests and the increased availability of multi-analyte control. Validation analysis. The accuracy of the immunoassay test menu.
However, due to the increasing acceptance of personalized medicines and the increase in the number of molecular diagnostic tests worldwide, the field of molecular diagnostics is expected to grow at the fastest compound annual growth rate of 5.3% during the forecast period 2022-2030. It is divided into four regions, including North America, Europe, Asia Pacific and LAMEA.
North America dominated the global IVD quality control market in 2015. Due to the increased demand for technologically advanced multi-analyte control and strict requirements for the use of controls, it is expected to continue to dominate during the forecast period. Due to the increase in the number of accredited laboratories in the region and the increase in the volume of IVD testing in the region, their compound annual growth rates are expected to be 4.9% and 4.1% respectively during the forecast period.
In addition, countries such as China and India provide important growth opportunities for market participants due to the increase in the number of hospitals and clinical pathology, the improvement of healthcare infrastructure, and the increase in health awareness. They are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Randox Laboratories Ltd., Roche Diagnostics, Abbott Diagnostics, Helena Laboratories, Seracare Life Sciences, Inc., Technopath Clinical Diagnostics, and Sun Diagnostics, LLC. IVD quality control industry participants (not included in the report) include Zeptometrix Corporation, ISOLAB GmbH, Sysmex Corporation, Fortress Diagnostics, Meril Life Sciences Pvt. Ltd., Multiplicom N.V., Future Diagnostics Solutions B.V. and Surmodics, Inc.
MAIN ADVANTAGE :
The in-depth analysis of the IVD quality control market is based on a comprehensive analysis of the factors driving and inhibiting the growth of the IVD industry market based on the market estimation report of key market segments during the period 2022-2030. The analysis of the market segment of the IVD quality control industry helps to understand the prospects of the IVD quality control products currently in use, as well as the variants that will gain a prominent position in the future. Competitive intelligence from leading manufacturers and distributors can help explain the regional competitive landscape. The report thoroughly analyzes the profiles and strategies of major market participants to understand the market competitive prospects.
IN VITRO DIAGNOSTICS QUALITY CONTROL PRODUCT KEY MARKET SEGMENTATIONA;
Quality control by product type Whole blood-based control Serum/plasma-based control Urine-based control Other IVD quality control data management solutions to ensure service quality According to the application of clinical chemistry immunity Chemical hematology molecular diagnostics manufacturer CoagroesearchUserHemostasis material relies on third-party control, party control, instrument manufacturer control. "
㱰
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
